NYC Brain Computer Startup Announces FDA Trial Before Elon Musk
Synchron’s devices could help paralysis patients control computers with their thoughts.
Thomas Oxley with the tiny Stentrode device.
Source: Synchron
This article is for subscribers only.
A brain-computer interface company is entering clinical trials for its implants in the U.S., a big step toward getting the futuristic devices into more skulls to help treat conditions like paralysis.
New York-based Synchron Inc. said it received permission from the Food and Drug Administration to test its device in human patients. The trial, known as an early feasibility study, is essential to proving the implants work safely and could one day be sold in the U.S.